three more acellular pertussis (DTaP) vaccines for INFANTS

The FDA is close to approving three more acellular pertussis (DTaP) vaccines for INFANTS. Infanrix from SKB...Acel-Imune from Lederle...and Certiva from Abbott.

Tripedia was just approved for infants this summer.

Acel-Imune is already on the market...but so far it's only approved for the fourth and fifth booster doses in children.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote